Sequencing of Phosphorodiamidate Morpholino Oligomers by Hydrophilic Interaction Chromatography Coupled to Tandem Mass Spectrometry.

Autor: Wang M; Sarepta Therapeutics, Inc., Cambridge, Massachusetts 02142, United States., O'Day B; Sarepta Therapeutics, Inc., Cambridge, Massachusetts 02142, United States., Michaels B; Sarepta Therapeutics, Inc., Cambridge, Massachusetts 02142, United States., Jurayj J; Sarepta Therapeutics, Inc., Cambridge, Massachusetts 02142, United States., Cai BZ; Sarepta Therapeutics, Inc., Cambridge, Massachusetts 02142, United States., Wei T; Sarepta Therapeutics, Inc., Cambridge, Massachusetts 02142, United States.
Jazyk: angličtina
Zdroj: Journal of the American Society for Mass Spectrometry [J Am Soc Mass Spectrom] 2024 Oct 02; Vol. 35 (10), pp. 2490-2498. Date of Electronic Publication: 2024 Aug 30.
DOI: 10.1021/jasms.4c00281
Abstrakt: Sequencing of phosphorodiamidate morpholino oligomers (PMOs) by hydrophilic interaction chromatography (HILIC) coupled to tandem mass spectrometry (MS/MS) is reported. The MS/MS analysis was performed using a quadrupole/time-of-flight (Q-ToF) mass analyzer and collision induced dissociation (CID) in negative ion mode. To improve MS sensitivity in negative ion mode, HILIC conditions, including the separation column, mobile phases, and MS parameters, were optimized. Using the developed HILIC-CID-MS/MS method, 100% sequence coverage was achieved for PMOs ranging from 18-mer to 25-mer. Additionally, the method was successfully applied to identifying positional isomers of n - 1 deletion impurities present in PMO drug substances.
Databáze: MEDLINE